MENU
+Compare
KNSA
Stock ticker: NASDAQ
AS OF
Jan 22, 10:30 AM (EDT)
Price
$18.57
Change
-$0.14 (-0.75%)
Capitalization
1.35B

KNSA Kiniksa Pharmaceuticals International plc Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

Industry Biotechnology
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KNSA with price predictions
Jan 08, 2025

KNSA sees its Stochastic Oscillator recovers from oversold territory

On January 03, 2025, the Stochastic Oscillator for KNSA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 08, 2025. You may want to consider a long position or call options on KNSA as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KNSA advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 50-day moving average for KNSA moved below the 200-day moving average on January 03, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KNSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KNSA entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KNSA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.091) is normal, around the industry mean (15.017). P/E Ratio (164.538) is within average values for comparable stocks, (88.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.838). KNSA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (3.546) is also within normal values, averaging (265.166).

View a ticker or compare two or three
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

KNSA is expected to report earnings to fall 116.67% to 2 cents per share on February 26

Kiniksa Pharmaceuticals International plc KNSA Stock Earnings Reports
Q4'24
Est.
$0.03
Q3'24
Missed
by $0.19
Q2'24
Beat
by $0.02
Q1'24
Missed
by $0.11
Q4'23
Beat
by $0.46
The last earnings report on October 29 showed earnings per share of -18 cents, missing the estimate of 0 cents. With 711.96K shares outstanding, the current market capitalization sits at 1.35B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGFRX22.850.39
+1.74%
Invesco EQV International Equity R6
WWWEX17.630.17
+0.97%
Kinetics Global No Load
HICVX21.020.15
+0.72%
Hennessy Cornerstone Value Inst
MALOX18.97N/A
N/A
BlackRock Global Allocation Instl
HMECX18.84-0.01
-0.05%
NexPoint Merger Arbitrage C

KNSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with FATE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.92%
FATE - KNSA
44%
Loosely correlated
+3.94%
ABVC - KNSA
40%
Loosely correlated
+0.22%
NTLA - KNSA
40%
Loosely correlated
+4.63%
TRDA - KNSA
39%
Loosely correlated
+2.92%
BEAM - KNSA
39%
Loosely correlated
+4.65%
More

Groups containing KNSA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.92%
Pharmaceuticals
category (309 stocks)
26%
Poorly correlated
+1.37%